Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
Guardant Health (Nasdaq: GH), a precision oncology company, has announced it will release its fourth quarter and full year 2024 financial results after market close on Thursday, February 20, 2025. The company will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results. Investors can access the live audio webcast through the company's website, and a replay will be available after the event.
Guardant Health (Nasdaq: GH), un'azienda specializzata in oncologia di precisione, ha annunciato che rilascerà i propri risultati finanziari del quarto trimestre e dell'intero anno 2024 dopo la chiusura del mercato il giovedì 20 febbraio 2025. L'azienda ospiterà una conferenza telefonica e una diretta web alle 13:30 ora del Pacifico / 16:30 ora dell'Est lo stesso giorno per discutere i risultati. Gli investitori possono accedere alla diretta audio tramite il sito web dell'azienda, e una registrazione sarà disponibile dopo l'evento.
Guardant Health (Nasdaq: GH), una empresa de oncología de precisión, ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el jueves 20 de febrero de 2025. La empresa llevará a cabo una conferencia telefónica y una transmisión en vivo a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este el mismo día para discutir los resultados. Los inversores pueden acceder a la transmisión de audio en vivo a través del sitio web de la empresa, y una repetición estará disponible después del evento.
가드란트 헬스(나스닥: GH), 정밀 종양학 회사가 2024년 4분기 및 연간 재무 결과를 2025년 2월 20일 목요일 시장 마감 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 1시 30분 태평양 표준시 / 오후 4시 30분 동부 표준시에 결과에 대해 논의하기 위해 컨퍼런스 콜과 웹캐스트를 진행할 것입니다. 투자자들은 회사 웹사이트를 통해 생중계 오디오 웹캐스트에 접근할 수 있으며, 이벤트 후 재생이 가능합니다.
Guardant Health (Nasdaq: GH), une entreprise d'oncologie de précision, a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année entière 2024 après la fermeture du marché le jeudi 20 février 2025. L'entreprise organisera une conférence téléphonique et un webinaire à 13h30 heure du Pacifique / 16h30 heure de l'Est le même jour pour discuter des résultats. Les investisseurs peuvent accéder au webinaire audio en direct via le site Web de l'entreprise, et un enregistrement sera disponible après l'événement.
Guardant Health (Nasdaq: GH), ein Unternehmen der präzisen Onkologie, hat angekündigt, dass es nach Börsenschluss am Donnerstag, den 20. Februar 2025 seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr Pazifische Zeit / 16:30 Uhr Eastern Zeit eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu erörtern. Investoren können auf den Live-Audio-Webcast über die Website des Unternehmens zugreifen, und eine Wiederholung wird nach der Veranstaltung verfügbar sein.
- None.
- None.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will be archived and available for replay after the event.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250130269724/en/
Investor Contact:
Zarak Khurshid
investors@guardanthealth.com
Media Contact:
Melissa Marasco
press@guardanthealth.com
+1 650-647-3711
Source: Guardant Health, Inc.
FAQ
When will Guardant Health (GH) release Q4 and full year 2024 earnings?
What time is Guardant Health's (GH) Q4 2024 earnings call?
How can investors access Guardant Health's (GH) Q4 2024 earnings webcast?